
1. Hadley ME, et al. Discovery and development of melanocortin peptides. *Ann N Y Acad Sci*. 1999;885:1–21. doi:10.1111/j.1749-6632.1999.tb08661.x
2. Wessells H, et al. Melanocortin receptor agonists and sexual function. *Urology*. 2000;55(5):755–759. doi:10.1016/S0090-4295(00)00451-4
3. Shadiack AM, et al. Melanotan II: effects on sexual behavior in male rats. *Pharmacol Biochem Behav*. 2003;76(3-4):355–362. doi:10.1016/S0091-3057(03)00218-1
4. Diamond LE, et al. Melanotan-II induces penile erection in men with psychogenic erectile dysfunction. *Urology*. 1999;54(4):755–759. doi:10.1016/S0090-4295(99)00226-9
5. Wessells H, et al. Effect of an MC4R agonist (Melanotan-II) on sexual desire and arousal in women. *J Clin Endocrinol Metab*. 2000;85(10):3862–3869. doi:10.1210/jcem.85.10.6895
6. Wikberg JE. Melanocortin receptors: structure and function. *Regul Pept*. 1999;85(1):95–105. doi:10.1016/S0167-0115(99)00088-3
7. Cowley MA, et al. Melanocortin receptors and regulation of appetite. *Nature*. 1999;400(6741):265–269. doi:10.1038/22307
8. Hruby VJ, et al. Structure-activity relationships of melanocortin peptides: design of potent MT-II analogues. *Peptides*. 1998;19(6):993–1000. doi:10.1016/S0196-9781(98)00053-2
9. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical overview and future directions. *Peptides*. 2006;27(4):921–930. doi:10.1016/j.peptides.2005.05.019
10. van der Ploeg LH, et al. Melanotan-II (MT-II) enhances tanning and reduces appetite in humans. *Nat Med*. 2002;8(4):401–407. doi:10.1038/nm0402-401
2. Wessells H, et al. Melanocortin receptor agonists and sexual function. *Urology*. 2000;55(5):755–759. doi:10.1016/S0090-4295(00)00451-4
3. Shadiack AM, et al. Melanotan II: effects on sexual behavior in male rats. *Pharmacol Biochem Behav*. 2003;76(3-4):355–362. doi:10.1016/S0091-3057(03)00218-1
4. Diamond LE, et al. Melanotan-II induces penile erection in men with psychogenic erectile dysfunction. *Urology*. 1999;54(4):755–759. doi:10.1016/S0090-4295(99)00226-9
5. Wessells H, et al. Effect of an MC4R agonist (Melanotan-II) on sexual desire and arousal in women. *J Clin Endocrinol Metab*. 2000;85(10):3862–3869. doi:10.1210/jcem.85.10.6895
6. Wikberg JE. Melanocortin receptors: structure and function. *Regul Pept*. 1999;85(1):95–105. doi:10.1016/S0167-0115(99)00088-3
7. Cowley MA, et al. Melanocortin receptors and regulation of appetite. *Nature*. 1999;400(6741):265–269. doi:10.1038/22307
8. Hruby VJ, et al. Structure-activity relationships of melanocortin peptides: design of potent MT-II analogues. *Peptides*. 1998;19(6):993–1000. doi:10.1016/S0196-9781(98)00053-2
9. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical overview and future directions. *Peptides*. 2006;27(4):921–930. doi:10.1016/j.peptides.2005.05.019
10. van der Ploeg LH, et al. Melanotan-II (MT-II) enhances tanning and reduces appetite in humans. *Nat Med*. 2002;8(4):401–407. doi:10.1038/nm0402-401